Slate Path Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Slate Path Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$160M	Sell
2025 Q2	$139M	Sell
2025 Q1	$148M	Buy
2024 Q4	$187M	Sell
2024 Q3	$246M	Sell
2024 Q2	$328M	Sell
2024 Q1	$380M	Buy
2023 Q4	$274M	Buy
2023 Q3	$243M	Buy
2023 Q2	$93.7M	Buy